Century Life Technology teams up with Nebula Computer to publicly acquire 37.8% stake in Tianliang Biotech
Century Life Technology, under the Shining Group, announced a joint public tender offer with Nebula Computer to acquire 37.8% of Tianliang Biotech's shares. This strategic move aims to accelerate the construction of an "AI Smart Grand Health Ecosystem" in response to Taiwan's aging society.
📋 Article Processing Timeline
- 📰 Published: May 13, 2026 at 23:43
- 🔍 Collected: May 14, 2026 at 00:02 (19 min after Published)
- 🤖 AI Analyzed: May 14, 2026 at 03:10 (3h 7m after Collected)
Central News Agency
(Central News Agency reporter Pan Chih-yi, Taipei, 13th) Century Life Technology, a subsidiary of Shining Group, today announced that it will jointly launch a public tender offer for Tianliang Biotechnology with Nebula Computer. This joint public tender offer is expected to acquire 17,298,000 common shares of Tianliang Biotech, accounting for approximately 37.8% of its total issued shares, at a tender offer price of NT$32.71 per share, for a total acquisition amount of approximately NT$565,817,580.
Century Life Technology explained that the tender offer period for Tianliang Biotech will be from May 15, 2026, to June 30, 2026. The entire case will be handled in accordance with relevant laws and regulations such as the "Business Mergers and Acquisitions Act" and the "Regulations Governing Public Tender Offers for Securities of Public Companies," and will be reported and announced to the competent authorities in accordance with the law to ensure transparent information disclosure and fully protect investors' rights.
Century Life Technology pointed out that as Taiwan officially enters an aging society, the demand from the senior population for health foods, daily health management, and anti-aging related products continues to rise. The grand health industry has become a key strategic market with long-term growth potential. Century Life Technology has actively deployed in health products, e-commerce channels, and smart application fields in recent years. This joint acquisition of Tianliang Biotech with Nebula Computer will become a core node connecting products, channels, and the end consumer market, completing a key piece of the group's "AI Smart Grand Health Ecosystem."
In addition, Shining Group will simultaneously layout preventive medical businesses through strategic investments, guiding research and development towards higher value-added product areas, achieving the synergy of technological upgrading and industrial transformation.
Furthermore, after the acquisition is completed, the three parties will integrate three core assets: "AI Smart Grand Health, global brand channels, and an independent media ecosystem for health foods."
Tianliang Biotech has a complete product line, is certified by the Ministry of Health and Welfare's GDP, and has a deep physical channel foundation with close cooperation with over 3,000 pharmacies across Taiwan. Century Life Technology and Nebula Computer will cooperate to promote its operational upgrade, accelerate the launch of high value-added new products, introduce Century Life Technology's Chaowei Biomedical's exosome patent Eob686 and "AI Nutritionist" service, and promote them to the middle-aged and elderly health care population through Tianliang's physical channel network.
Through Century Life Technology's existing e-commerce platform and channel advantages, combined with Tianliang Biotech's physical channels and satellite TV resources, an Online-Merge-Offline (OMO) marketing synergy will be achieved, expanding market penetration and brand expansion. Combined with Nebula Computer's experience in international strongholds in the United States and the Netherlands, it will assist Tianliang's brand in expanding its global footprint. (Edited by Chang Chun-Mao) 1150513
Choose to stand with facts, every sponsorship you provide is a force for safeguarding press freedom.
Download the Central News Agency's "First-hand News" APP to stay updated with the latest news.
The text, images, and audio-visual content on this website may not be reproduced, publicly broadcast, publicly transmitted, or utilized without authorization.
(Central News Agency reporter Pan Chih-yi, Taipei, 13th) Century Life Technology, a subsidiary of Shining Group, today announced that it will jointly launch a public tender offer for Tianliang Biotechnology with Nebula Computer. This joint public tender offer is expected to acquire 17,298,000 common shares of Tianliang Biotech, accounting for approximately 37.8% of its total issued shares, at a tender offer price of NT$32.71 per share, for a total acquisition amount of approximately NT$565,817,580.
Century Life Technology explained that the tender offer period for Tianliang Biotech will be from May 15, 2026, to June 30, 2026. The entire case will be handled in accordance with relevant laws and regulations such as the "Business Mergers and Acquisitions Act" and the "Regulations Governing Public Tender Offers for Securities of Public Companies," and will be reported and announced to the competent authorities in accordance with the law to ensure transparent information disclosure and fully protect investors' rights.
Century Life Technology pointed out that as Taiwan officially enters an aging society, the demand from the senior population for health foods, daily health management, and anti-aging related products continues to rise. The grand health industry has become a key strategic market with long-term growth potential. Century Life Technology has actively deployed in health products, e-commerce channels, and smart application fields in recent years. This joint acquisition of Tianliang Biotech with Nebula Computer will become a core node connecting products, channels, and the end consumer market, completing a key piece of the group's "AI Smart Grand Health Ecosystem."
In addition, Shining Group will simultaneously layout preventive medical businesses through strategic investments, guiding research and development towards higher value-added product areas, achieving the synergy of technological upgrading and industrial transformation.
Furthermore, after the acquisition is completed, the three parties will integrate three core assets: "AI Smart Grand Health, global brand channels, and an independent media ecosystem for health foods."
Tianliang Biotech has a complete product line, is certified by the Ministry of Health and Welfare's GDP, and has a deep physical channel foundation with close cooperation with over 3,000 pharmacies across Taiwan. Century Life Technology and Nebula Computer will cooperate to promote its operational upgrade, accelerate the launch of high value-added new products, introduce Century Life Technology's Chaowei Biomedical's exosome patent Eob686 and "AI Nutritionist" service, and promote them to the middle-aged and elderly health care population through Tianliang's physical channel network.
Through Century Life Technology's existing e-commerce platform and channel advantages, combined with Tianliang Biotech's physical channels and satellite TV resources, an Online-Merge-Offline (OMO) marketing synergy will be achieved, expanding market penetration and brand expansion. Combined with Nebula Computer's experience in international strongholds in the United States and the Netherlands, it will assist Tianliang's brand in expanding its global footprint. (Edited by Chang Chun-Mao) 1150513
Choose to stand with facts, every sponsorship you provide is a force for safeguarding press freedom.
Download the Central News Agency's "First-hand News" APP to stay updated with the latest news.
The text, images, and audio-visual content on this website may not be reproduced, publicly broadcast, publicly transmitted, or utilized without authorization.